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This single-center study is another piece of evidence in a
growing wave of reports addressing important clinical outcomes
after endovascular treatment of thoracic aortic pathology. In Table
III, the authors specifically segregate outcomes in patients who did
and did not have left subclavian artery revascularization, and the
comparisons are striking, with a 28% risk of combined stroke,
paraplegia, or death when the left subclavian artery was not revas-
cularized compared with none when it was revascularized. Their
analysis may be confounded by the nonrandomized design in
which they more recently have routinely performed the subclavian
revascularization, and they have certainly improved other compo-
nents of their institutional systems. Further confounding may
occur with emergency cases, when staged or simultaneous revas-
cularization may not be possible.
Taken together with other reports, these institutional experi-
ences from centers of excellence with thoracic endovascular aortic
repair are painting an impressive picture. In a recent meta-analysis
of 51 eligible studies, sponsored by the Society for Vascular Sur-
gery, the Mayo Clinic Knowledge and Encounter Research Unit
found risks increased by odds ratios of 47.7 for arm ischemia, 10.8
for vertebrobasilar ischemia, 2.69 for spinal cord ischemia, and
2.58 for anterior circulation stroke with left subclavian coverage
without revascularization compared with revascularization.1
The clinical practice guidelines of the Society for Vascular
Surgery “suggest” routine preoperative revascularization when theleft subclavian artery is covered. They provide a stronger “recom-
mend” routine revascularization in circumstances where collateral
perfusion may be compromised.2 Unfortunately, the evidence
supporting these recommendations is very low quality, and there
are no randomized data that provide stronger evidence for deci-
sions being made today.
It is not surprising there are worse outcomes with occlusion of
a major aortic arch vessel compared with strategies that maintain
antegrade flow in the left subclavian artery. Vertebral, internal
thoracic, and thoracodorsal arteries can be major contributors of
brain and spinal cord collateral blood flow. This St. George’s
Vascular Institute report is another contribution to the evidence
favoring revascularization of the left subclavian artery.
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